GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Current Accrued Expense

Aptamer Group (LSE:APTA) Current Accrued Expense : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Current Accrued Expense?

Aptamer Group's Current Accrued Expense for the quarter that ended in Dec. 2023 was £0.00 Mil.


Aptamer Group Current Accrued Expense Historical Data

The historical data trend for Aptamer Group's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Current Accrued Expense Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23
Current Accrued Expense
- - - -

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23
Current Accrued Expense Get a 7-Day Free Trial - - - - -

Aptamer Group Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Aptamer Group Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptamer Group Business Description

Traded in Other Exchanges
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group Headlines

No Headlines